Perspectum Diagnostics has developed a novel way of using multiparametric Magnetic Resonance Imaging (MRI) to characterize liver tissue. Their flagship product, LiverMultiScan™ provides quantitative measures of fat and correlates of iron and fibroinflammatory disease. Research has shown that multiparametric MRI can detect even early liver disease, which could be useful in helping patients to make lifestyle alterations before disease progression. There is a burgeoning interest in using LiverMultiScan™ in clinical practice, as well as in pharmaceutical trials to screen at-risk populations and test efficacy of new treatments. LiverMultiScan™ can maximise the use of your MR in clinical trials, and clinical practice. Perspectum will also showcase their latest work at RSNA 2017, which allows 3D visualisation and quantitative mapping of the biliary tree by enhancing conventional MRCP.